Lenvatinib plus Pembrolizumab Following Immune Checkpoint Inhibitor Treatment in Patients with Metastatic Clear Cell Renal Cell Carcinoma: Results from Study 111/KEYNOTE-146.

Document Type

Article

Publication Date

5-21-2024

Publication Title

European urology

Keywords

oregon; chiles

Clinical Institute

Cancer

Specialty

Oncology

Share

COinS